Sign In

Chad Bigelow

Director at Novartis Institutes for BioMedical Research (NIBR)

Chad Bigelow is a researcher at Novartis Institutes for Biomedical Research Inc. (NIBR).1 He has been involved in experimental gene therapy research at Novartis, contributing to the design and laboratory testing of new treatments.2 Bigelow has been a member of SPIE (an international society for optics and photonics) for 7 years1, suggesting he has expertise in optical or photonic technologies relevant to his work at NIBR. His involvement with SPIE indicates that his research may involve optical imaging or other light-based techniques in biomedical applications.

Highlights

Mar 21 · novartis.com
Experimental gene therapy discovered in-house enters clinical testing
Experimental gene therapy discovered in-house enters clinical testing
Jan 1 · spie.org
Chad Bigelow - SPIE

Related Questions

What are Chad Bigelow's main responsibilities at Novartis Institutes for BioMedical Research?
What projects has Chad Bigelow led at Novartis?
How did Chad Bigelow contribute to the development of the experimental gene therapy?
What is Chad Bigelow's background before joining Novartis?
What are some notable achievements of Chad Bigelow in the field of biomedical research?
Chad Bigelow
Chad Bigelow, photo 1
Chad Bigelow, photo 2
Add to my network

Location

Cambridge, Massachusetts, United States